Background: Cardiovascular, Kidney and metabolic syndrome (CKM) is a complex disease, for which current therapeutic approaches have limited efficacy. This study aims to screen for potential targets and novel drugs for treating CKM using network pharmacology.
Methods: Using reverse network pharmacology, core targets and potential drugs for CKM were identified.
Objective: Chronic respiratory diseases (CRDs) and cardiovascular diseases (CVD) share common risk factors and frequently co-occur, leading to poorer outcomes. Life's Essential 8 (LE8), a novel metric for cardiovascular health, may provide insights into this association. This study investigates the relationship between LE8 and CRDs to identify modifiable factors for targeted prevention.
View Article and Find Full Text PDF